Synthetic estrogen can cause reproductive issues in offspring

Women whose mothers were given diethylstilbestrol (DES) while pregnant are more likely to have reproductive problems and are predisposed to cancer and pre-cancerous conditions. DES was the first synthetic form of estrogen and was used until the mid-1950s. Researchers at the National Cancer Institute used the presence of vaginal epithelial changes as a biomarker to determine what conditions were mostly likely to cause harm to female offspring. They found that babies who'd been exposed to high doses of DES early in development were more likely to experience certain medical conditions compared to those who were not exposed to the hormone. Release

Suggested Articles

Sanofi will look to pull back from its three-year-old relationship with Verily and their virtual diabetes clinic, Onduo.

AstraZeneca is linking up with DeepMatter, a big data firm focused on achieving reproducibility in chemistry, to help improve its compound synthesis.

Boehringer Ingelheim tapped Healx to help identify new drug indications and leverage its AI to explore R&D options in neurological diseases.